HAYA Therapeutics

Programming lasting health

Lausanne, Switzerland · Founded 2019 · $62.0M raised

Headquarters
Lausanne
Employees
11–50
Founded
2019
Business Model
B2B
Website
hayatx.com
Total Funding
$62.0M
Last Round
$62.0M Series AMay 2025
Rounds
1

About

HAYA Therapeutics is a precision medicine company developing RNA-guided programmable therapeutics that target the regulatory genome — the 98% of the genome that doesn't code for proteins — to reverse disease-driving cell states. The company's platform integrates multimodal functional genomics with proprietary computational tools to discover and drug long non-coding RNAs (lncRNAs) that causally drive fibrotic and other serious diseases.

Summary

HAYA Therapeutics is a Biotech company based in Lausanne, Switzerland, founded in 2019. It has raised $62.0M in total across 1 round, most recently a $62.0M Series A round in May 2025.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2025
$62.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HAYA Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/haya-therapeutics"><img src="https://indexed.vc/api/badge/company/haya-therapeutics" alt="HAYA Therapeutics on Indexed.vc" width="260" height="76" /></a>